JP MORGAN/CALL/EDWARDS LIFESCIENCES/125/0.1/17.01.25

JP MORGAN/CALL/EDWARDS LIFESCIENCES/125/0.1/17.01.25 Stock

DE000JL1J238

Real-time Bid/Ask 07:21:36 2024-06-03 am EDT
0.082 ^EUR / 0.15 ^EUR	+84.13%

1 month	-4.55%
3 months	-51.54%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart EDWARDS LIFESCIENCES CORPORATION

Chart JP MORGAN/CALL/EDWARDS LIFESCIENCES/125/0.1/17.01.25

Latest news about EDWARDS LIFESCIENCES CORPORATION

Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Division for $4.2 Billion in Cash	07:13am	MT
Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln	06:50am	RE
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion	06:48am	MT
BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader	06:31am	PR

More news

Quotes 5-day view

Date	Price	Change
24-06-03	0.06	-4.76%
24-05-31	0.063	+31.25%
24-05-30	0.048	-2.04%
24-05-29	0.049	-18.33%
24-05-28	0.06	0.00%

Delayed Quote Börse Stuttgart

Last update June 03, 2024 at 03:58 am EDT

More quotes

Static data

Product type	Warrants
Buy / Sell	CALL
Underlying	EDWARDS LIFESCIENCES CORPORATION
Issuer	J.P. Morgan
WKN	JL1J23
ISIN	DE000JL1J238
Date issued	2023-04-06
Strike	125 $
Maturity	2025-01-17 (229 Days)
Parity	10 : 1
Emission price	0.38 €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	0.62 €
Lowest since issue	0.036 €
Delta	0x
Omega	0.000000
Premium	0x
Gearing	111.82x
Moneyness	1.115
Difference Strike	38.11 $
Difference Strike %	+30.49%
Spread	0.07 €
Spread %	46.67%
Intrinsic value	1.328
Present value	-1.212552

Company Profile

Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (67.9%); - hemodynamic monitoring systems (15.5%); - other (16.6%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).

Sector

More about the company

Ratings for Edwards Lifesciences Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Consensus: Edwards Lifesciences Corporation

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

86.89 USD

Average target price

96.55 USD

Spread / Average Target

+11.12%

Consensus